The open-label, randomized trial by Philips and colleagues reported that 5% albumin for initial fluid resuscitation in patients with septic cirrhosis had more hypotension reversal at 3 h per vital sign improvements than crystalloids, and a greater proportion of patients surviving at 7 days in the albumin group [11]. Here, ALB is linked to Cirrhosis.